Iradimed corporation announces uplisting to the nasdaq global market

Winter springs, fla., june 07, 2024 (globe newswire) -- iradimed corporation (“iradimed”) (nasdaq: irmd), a leading provider of innovative magnetic resonance imaging (mri) compatible medical devices, announced today its common stock will uplist and commence trading on the nasdaq global market, effective june 14, 2024, and will continue under the ticker symbol “irmd.
NDAQ Ratings Summary
NDAQ Quant Ranking